Citations

Clear

3314 citation(s) found for "Yu, Alexander".

IL-17 signaling in primary sclerosing cholangitis patient-derived organoids
Moreno, A. , Guicciardi, Maria Eugenia , Wixom, Alexander Q. , Jessen, Erik , Yang, Jingchun , Ilyas, Sumera I. , Bianchi, Jackie K., Lazaridis, Konstantinos N. , Gores, Gregory J. , Gores, Gregory J. , Garcia Moreno, Ana S , Guicciardi, Maria E , Vairo, Filippo , Lazaridis, Konstantinos N , Ilyas, Sumera Irie , Wixom, Alexander Q , Vairo, Filippo Pinto e

Mayo Clinic

Hepatology Communications | June 3, 2024 | Volume: 8 | Issue: 6 | Pages: No page available

10.1097/hc9.0000000000000454 | PMID 38829197 Get It

Background: The pathogenesis of primary sclerosing cholangitis (PSC) is unclear, although studies implicate IL-17A as an inflammatory mediator in this disease. However, a direct assessment of IL-17 signaling in PSC cholangiocytes is lacking. In this study, we aimed to investigate and characterize the response of PSC extrahepatic cholangiocyte organoids (ECO) to IL-17A stimulation. Methods: Cholangiocytes obtained from patients with PSC and without PSC by endoscopic retrograde cholangiography were cultured as ECO. The ECO were treated with vehicle or IL-17A and assessed by transcriptomics, secretome analysis, and genome sequencing. Results: Unsupervised clustering of all integrated single-cell RNA sequencing data identified 8 cholangiocyte clusters that did not differ between PSC and non-PSC ECO. However, PSC ECO cells demonstrated a robust response to IL-17 treatment, as noted by an increased number of differentially expressed genes by transcriptomics and more abundant chemokine and cytokine expression and secretion. After rigorous filtering, genome sequencing identified candidate somatic variants shared among PSC ECO from unrelated individuals. However, no candidate rare variants in genes regulating the IL-17 pathway were identified, but rare variants regulating the MAPK signaling pathway were present in all PSC ECO. Conclusions: PSC and non-PSC patient-derived ECO respond differently to IL-17 stimulation, implicating this pathway in the pathogenesis of PSC.
Arthroscopic Subpectoral Tenodesis of the Long Head of the Biceps Brachii
Hoffer, Alexander J , Tokish, John M.

Mayo Clinic

Arthroscopy Techniques | June 1, 2024 | Volume: 13 | Issue: 10 | Pages: No page available

10.1016/j.eats.2024.103079 | PMID 39479051 Get It

Abstract The long head of the biceps brachii is a common pain generator in the shoulder that is often managed surgically with tenotomy or tenodesis. The clinical outcomes after tenotomy and tenodesis are comparable. However, tenodesis is preferred in the active population owing to complications associated with tenotomy, including cosmetic deformity, early fatigue, and cramping. Controversy surrounds both the approach and location of tenodesis. Both open and arthroscopic techniques have been described. An arthroscopic approach is used for tenodesis within the intertubercular groove between the humeral head articular margin and superior border of the pectoralis major but has the drawback of pathologic tendon retained in the groove. An open approach is generally reserved for subpectoral tenodesis, which has the advantage of no retained pathologic tendon but has the drawbacks of an open approach. We describe an all‐arthroscopic technique for subpectoral tenodesis of the long head of the biceps brachii at the lower border of the pectoralis major. Technique Video video See video under supplementary data.
Race-Neutral z -Score Classification of Airflow Obstruction: A Measured Step Forward
Kanj, Amjad , Niven, Alexander S. , Kanj, Amjad N , Niven, Alexander S

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 31, 2024 | Volume: 210 | Issue: 11 | Pages: 1287-1289

10.1164/rccm.202404-0873ed | PMID 38820133 Get It

Evaluation of the cutaneous blood supply and vascular territories of the wrist
Alder, Kareme D. , Kattil, Punnose , Lachman, Nirusha , Shin, Alexander Y. , Shin, Alexander Y , Kattil, Punnose K , Meaike, Joshua J. , Pulos, Nicholas

Mayo Clinic

Orthoplastic Surgery | May 30, 2024 | Volume: 16 | Issue: C | Pages: 20-30

10.1016/j.orthop.2024.05.002 Get It

ABSTRACT Purpose: To determine and evaluate the distal forearm and wrist's cutaneous blood supply and vascular territories. Methods: Four cadaveric upper extremities were injected with a radiopaque, lead-based contrast agent through the brachial artery. After the lead-based contrast agent set, the cadaveric limbs underwent computed tomographic (CT) scanning to assess the perforators to the cutaneous skin of the distal forearm and wrist. High-resolution axial CT and three-dimensional reconstructions were generated to highlight perforating vessels stemming from their parent arteries. Subsequently, anatomic microdissections were performed to identify and trace the perforating vessels identified on CT. Results: CT analysis and anatomic microdissection demonstrated that the dorsal surface of the distal forearm and wrist are supplied by numerous perforators stemming predominantly from the anterior interosseous artery with some anastomotic contribution from the posterior interosseous, radial, and ulnar arteries. Perforators from the radial and ulnar arteries supply the volar surface. There are large anastomotic networks formed between the perforating vessels. Conclusions: The distal forearm and wrist have a robust anastomotic blood supply that has contributions from the anterior interosseous, posterior interosseous, radial, and ulnar arteries. Clinical relevance: The extensive perforator-derived blood supply to the skin likely accounts for the excellent soft tissue healing potential of the wrist following surgery utilizing multiple incisions. Highlights Distal radius fractures may require multiple incisions for anatomic reduction and fixation.Multiple incisions about the wrist are thought to predispose to wound complications and/or skin breakdown.The distal forearm and wrist have a robust anastomotic blood supply from the anterior interosseous, posterior interosseous, radial, and ulnar arteries.Multiple incisions do not necessarily predispose to wound complications given robust anastamosis.
Interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy: ECOG-ACRIN EA1211/DIRECT trial.
Hennessy, Maeve, Gatsonis, Constantine, Jacene, Heather A. , Connolly, Roisín M. , Burnette, Brian L., Stringer-Reasor, Erica , Taurone, Alexander, O’Sullivan, Ciara C. , Le‐Petross, Huong T. , Sepulveda, Karla A., Romanoff, Justin , Lawhn-Heath, Courtney A. , Stearns, Vered , Fowler, Amy M. , Tang, Shou-Ching , DeMichele, Angela , Mankoff, David A. , Wolff, Antonio C.

Mayo Clinic

Journal of Clinical Oncology | May 29, 2024 | Volume: 42 | Issue: 16_suppl | Pages: TPS614-TPS614

10.1200/jco.2024.42.16_suppl.tps614 Get It

TPS614 Background: Strategies to optimize treatment decision-making in early stage HER2-positive breast cancer are a priority. Recent studies suggest that early metabolic changes on FDG-PET/CT predict response to HER2-directed therapy. The TBCRC026 trial showed that participants not obtaining a 40% reduction in SULmax by cycle 1 day 15 (C1D15) following neoadjuvant trastuzumab/pertuzumab (HP) were unlikely to obtain pCR [negative predictive value (NPV) 91%]. This trial aims to validate FDG-PET/CT as a neoadjuvant interim (niFDG-PET/CT) imaging integral biomarker in patients treated with standard HER2-directed regimens (NCT05710328). Methods: Trial design: EA1211/DIRECT is a multicenter, single-arm, primary imaging phase 2 study enrolling patients with stage II/III HER2-positive breast cancer. Patients undergo standard skull base-thigh FDG-PET/CT at baseline and C1D15 and receive standard of care pertuzumab-based neoadjuvant therapy followed by surgery. Eligibility: Age ≥18 years, ECOG performance status 0-2, stage IIa-IIIc, untreated HER2-positive breast cancer with known hormone receptor status, suitable to undergo FDG-PET/CT imaging and neoadjuvant therapy. Statistical methods: ΔSULmaxD15 will be computed as: (D15 SULmax – baseline SULmax)/baseline SULmax. The primary objective is to estimate the NPV of niFDG-PET/CT for pCR using ΔSULmaxD15 of the primary breast cancer at a threshold of 40%. NPV is defined as the probability that pCR will not be achieved by participants with ΔSULmaxD15 <40%. Secondary endpoints include evaluating sensitivity, specificity, and positive predictive value of ΔSULmaxD15 of the primary breast cancer at a threshold of 40% and ability of the niFDG-PET/CT biomarker to predict 3-year event free survival (EFS). Sample size: We expect that 50% of patients will not reach the ΔSULmax threshold of 40% and a pCR rate of 40-60%. The proposed sample size is 210 participants, adjusted to 235 to account for missing data in 10% of cases. Computation of exact, two-sided 95% confidence intervals (CI) for NPV determined the lower limit of the CI is at least 80% when the true NPV is at least 88%. The lower limit is 84% when the true NPV has the value of 91%, which was estimated in the TBCRC026 study. Current status: EA1211/DIRECT was activated in May 2023 across the NCI National Clinical Trials Network (NCTN) and is anticipated to complete in March 2025. Those interested in the clinical trial can email ea1211team@ecog-acrin.org. The EA1211/DIRECT trial is the first step in implementing a Response-Guided Treatment Strategy by validating the ΔSULmax threshold of 40% as the optimum cut point across standard of care HER2-directed neoadjuvant regimens. If EA1211/DIRECT meets its objectives, the results will be used to design clinical utility studies, thus hoping to change practice. Clinical trial information: NCT05710328 .
Anaplastic sarcoma of the kidney ( DICER1 ‐sarcoma of the kidney): A report from the International Pleuropulmonary Blastoma/ DICER1 Registry
Schoettler, Peter , Smith, Caroline , Nishitani, Miki , Harris, Anne K. , Nelson, Alexander T. , Watson, Dave A., Kamihara, Junne , Mullen, Elizabeth A. , Messinger, Yoav H. , Fair, Douglas , Dehner, Louis P. , Ash, Shifra , Schultz, Kris Ann P. , Messinger, Yoav H , Fair, Douglas B , Ash, Shifra , Chen, Kenneth S , Schultz, Kris Ann P , Watson, Dave , Hill, Dana Ashley , Kumar, Kiran Achut , Chen, Kenneth

Mayo Clinic

Pediatric Blood & Cancer | May 28, 2024 | Volume: 71 | Issue: 8 | Pages: No page available

10.1002/pbc.31090 | PMID 38807260 Get It

Abstract Background Anaplastic sarcoma of the kidney (ASK) is a DICER1 ‐related neoplasm first identified as a distinctive tumor type through the evaluation of unusual cases of putative anaplastic Wilms tumors. Subsequent case reports identified the presence of biallelic DICER1 variants as well as progression from cystic nephroma, a benign DICER1 ‐related neoplasm. Despite increasing recognition of ASK as a distinct entity, the optimal treatment remains unclear. Methods Individuals with known or suspected DICER1 ‐related tumors including ASK were enrolled in the International Pleuropulmonary Blastoma/ DICER1 Registry. Additionally, a comprehensive review of reported cases of ASK was undertaken, and data were aggregated for analysis with the aim to identify prognostic factors and clinical characteristics to guide decisions regarding genetic testing, treatment, and surveillance. Results Ten cases of ASK were identified in the Registry along with 37 previously published cases. Staging data, per Children's Oncology Group guidelines, was available for 40 patients: 13 were stage I, 12 were stage II, 10 were stage III, and five were stage IV. Outcome data were available for 37 patients. Most (38 of 46) patients received upfront chemotherapy and 14 patients received upfront radiation. Two‐year event‐free survival (EFS) for stage I–II ASK was 81.8% (95% confidence interval [CI]: 67.2%–99.6%), compared with 46.6% EFS (95% CI: 24.7%–87.8%) for stage III–IV ( p = .07). Two‐year overall survival (OS) for stage I–II ASK was 88.9% (95% CI: 75.5%–100.0%), compared with 70.0% (95% CI: 46.7%–100.0%) for stage III–IV ( p = .20). Chemotherapy was associated with improved EFS and OS with hazard ratios of 0.09 (95% CI: 0.02–0.31) and 0.08 (95% CI: 0.02–0.42), respectively. Conclusion ASK is a rare DICER1 ‐related renal neoplasm. In the current report, we identify clinical and treatment‐related factors associated with outcome including the importance of chemotherapy in treating ASK. Ongoing data collection and genomic analysis are indicated to optimize outcomes for children and adults with these rare tumors.
Spatial analysis of recurrent glioblastoma reveals perivascular niche organization
Onubogu, Ugoma , Wolfe, Kelsey L., Oakes, Benjamin , Salatino, Roberto, Szentirmai, Oszkar, Janiszewska, Michalina , Vaubel, Rachael, Gatenbee, Chandler , Prabhakaran, Sandhya , Wolfe, Kristine , Vaubel, Rachael A. , Anderson, Alexander R.A.

Mayo Clinic

JCI Insight | May 28, 2024 | Volume: 9 | Issue: 12 | Pages: No page available

10.1172/jci.insight.179853 | PMID 38805346 Get It

Tumor evolution is driven by genetic variation; however, it is the tumor microenvironment (TME) that provides the selective pressure contributing to evolution in cancer. Despite high histopathological heterogeneity within glioblastoma (GBM), the most aggressive brain tumor, the interactions between the genetically distinct GBM cells and the surrounding TME are not fully understood. To address this, we analyzed matched primary and recurrent GBM archival tumor tissues with imaging-based techniques aimed to simultaneously evaluate tumor tissues for the presence of hypoxic, angiogenic, and inflammatory niches, extracellular matrix (ECM) organization, TERT promoter mutational status, and several oncogenic amplifications on the same slide and location. We found that the relationships between genetic and TME diversity are different in primary and matched recurrent tumors. Interestingly, the texture of the ECM, identified by label-free reflectance imaging, was predictive of single-cell genetic traits present in the tissue. Moreover, reflectance of ECM revealed structured organization of the perivascular niche in recurrent GBM, enriched in immunosuppressive macrophages. Single-cell spatial transcriptomics further confirmed the presence of the niche-specific macrophage populations and identified interactions between endothelial cells, perivascular fibroblasts, and immunosuppressive macrophages. Our results underscore the importance of GBM tissue organization in tumor evolution and highlight genetic and spatial dependencies.
Proximal Scaphoid Reconstruction Techniques Comparison of Three Techniques for Proximal Scaphoid Recontruction
Gil, Joseph A. , Burnier, Marion , Hooke, Alexander W. , Elhassan, Bassem T. , Kakar, Sanjeev , Hooke, Alexander , Kakar, Sanjeev

Mayo Clinic

Journal of Wrist Surgery | May 27, 2024 | Volume: 13 | Issue: 05 | Pages: 421-426

10.1055/s-0044-1786525 | PMID 39296655 Get It

Abstract Introduction The costo-osteochondral autograft, vascularized medial femoral trochlear osteochondral autograft, and proximal hamate autograft have been used for the reconstruction of unsalvageable proximal pole scaphoid nonunions. Our hypothesis is that there is no difference in carpal kinematics after the proximal pole of the scaphoid is reconstructed with these three graft options. Methods Wireless sensors were mounted to the carpus that was loaded through cyclical motion. Each specimen was tested under a series of the three reconstructed conditions and their kinematics compared. Results No significant differences were found in scapholunate and lunocapitate joint motion during wrist flexion-extension and wrist radioulnar deviation between the three reconstructed conditions (p > 0.05). Discussion and Conclusion There are minimal differences in carpal kinematics when comparing reconstruction of the proximal pole of the scaphoid with the costoosteochondral, medial femoral trochlear, and proximal hamate grafts.
Paediatric airway foreign-body removal equipment availability in sub-Saharan Africa
Kabagenyi, Fiona , Cherches, Alexander , Patel, Nina R. , Okerosi, Samuel , Xu, Mary Jue , Gellaw, Wale L. , Abdalla, Tagwa H.A. , Tshite, Felicia , Hlomani, Buhlebenkosi J. , Dzongodza, Titus , Maina, Reuel K. , Wiedermann, Joshua P. , Sidell, Douglas R. , Patel, Nina , Sidell, Douglas R. , Cherches, Alexander D , Okerosi, Samuel N , Peer, Shazia , Wiedermann, Joshua , Sidell, Douglas R , Din, Taseer , Peer, Shazia , Din, Taseer

Mayo Clinic

Journal of the Colleges of Medicine of South Africa | May 24, 2024 | Volume: 2 | Issue: 1 | Pages: No page available

10.4102/jcmsa.v2i1.45 | PMID 40949655 Get It

Sub-Saharan Africa (SSA), home to over 1 billion people, has only one paediatric otolaryngology fellowship program and nine fellowship-trained paediatric Otolaryngology Head and Neck Surgery (OHNS) specialists covering seven countries. Seven of these specialists estimated an average of 40+ patients per month are in need of critical surgical airway management in their respective countries and that 2–25 deaths per year (mainly paediatric) occur in their country from lack of access to foreign body removal equipment. Investing in paediatric airway infrastructure and capacity would largely benefit the health system in SSA, where the current lack of equipment alone leads to unmeasured morbidity and mortality. As a region of the world with the largest paediatric populations, sub-Saharan Africa’s need is all the more pressing given the disproportionately low number of medical specialists, institutions and resources. Collaborative approaches in procurement and maintenance of high-quality, cost-effective equipment are crucially desirable factors in both low- and middle-income countries (LMICs) and high-income countries (HICs). We, as the Global OHNS Initiative, urge for multi-stakeholder engagement and collaboration to forge lasting change.
Using Microfluidic Hepatic Spheroid Cultures to Assess Liver Toxicity of T-2 Mycotoxin
Taroncher, Mercedes , Gonzalez‐Suarez, Alan M. , Romero, Samuel, Reyes-Figueroa, A. D. , Rodríguez-Carrasco, Yelko , Ruiz, María-José , Stybayeva, Gulnaz , Revzin, Alexander , Hoyos‐Vega, José M. de , Reyes-Figueroa, Angel D , Rodríguez-Carrasco, Yelko , Ruiz, María-José , Stybayeya, Gulnaz , de Hoyos-Vega, Jose M , Gonzalez-Suarez, Alan M , Gwon, Kihak , Romero, Samuel

Mayo Clinic

Cells | May 24, 2024 | Volume: 13 | Issue: 11 | Pages: 900

10.3390/cells13110900 | PMID 38891032 Get It

The Fusarium fungi is found in cereals and feedstuffs and may produce mycotoxins, which are secondary metabolites, such as the T-2 toxin (T-2). In this work, we explored the hepatotoxicity of T-2 using microfluidic 3D hepatic cultures. The objectives were: (i) exploring the benefits of microfluidic 3D cultures compared to conventional 3D cultures available commercially (Aggrewell plates), (ii) establishing 3D co-cultures of hepatic cells (HepG2) and stellate cells (LX2) and assessing T-2 exposure in this model, (iii) characterizing the induction of metabolizing enzymes, and (iv) evaluating inflammatory markers upon T-2 exposure in microfluidic hepatic cultures. Our results demonstrated that, in comparison to commercial (large-volume) 3D cultures, spheroids formed faster and were more functional in microfluidic devices. The viability and hepatic function decreased with increasing T-2 concentrations in both monoculture and co-cultures. The RT-PCR analysis revealed that exposure to T-2 upregulates the expression of multiple Phase I and Phase II hepatic enzymes. In addition, several pro- and anti-inflammatory proteins were increased in co-cultures after exposure to T-2.